SEC Form 4 · accession 0001161697-18-000623
CATALYST PHARMACEUTICALS, INC. · CPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gary Ingenito
Officer — Chief Medical Officer
Period of report
Dec 19, 2018
Accepted (ET)
Dec 21, 2018 · 4:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369568
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to purchase common stock | $2.24 | Dec 19, 2018 | A | 75,000 | A | Dec 19, 2019 | Dec 19, 2025 | Common Stock | 75,000 | 910,000 | D |
| Options to purchase common stock | $2.24 | Dec 19, 2018 | A | 75,000 | A | Dec 19, 2020 | Dec 19, 2025 | Common Stock | 75,000 | 985,000 | D |
| Options to purchase common stock | $2.24 | Dec 19, 2018 | A | 75,000 | A | Dec 19, 2021 | Dec 19, 2025 | Common Stock | 75,000 | 1,060,000 | D |